Showing results (3211-3220 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|August 5, 2018
NGR-hTNF and Doxorubicin as Second-Line Treatment of Patients with Small Cell Lung CancerVanesa Gregorc, Raffaele Cavina, Sivia Novello, et al.
The Oncologist|August 5, 2018
Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology GroupAles Ryska, Rares Buiga, Albena Fakirova, et al.
The Oncologist|August 12, 2018
Wide Range of Clinical Outcomes in Patients with Gliomatosis Cerebri Growth Pattern: A Clinical, Radiographic, and Histopathologic StudyK Ina Ly, Derek H Oakley, Alexander B Pine, et al.
The Oncologist|May 13, 2017
Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of EncephalitisJames Larkin, Bartosz Chmielowski, Christopher D Lao, et al.
The Oncologist|May 11, 2017
Overall Survival and Clinical Characteristics of BRCA-Associated Cholangiocarcinoma: A Multicenter Retrospective StudyTalia Golan, Maria Raitses-Gurevich, Robin K Kelley, et al.
The Oncologist|September 25, 2016
Implementation of a Multicenter Biobanking Collaboration for Next-Generation Sequencing-Based Biomarker Discovery Based on Fresh Frozen Pretreatment Tumor Tissue BiopsiesSander Bins, Geert A Cirkel, Christa G Gadellaa-Van Hooijdonk, et al.
The Oncologist|May 4, 2017
Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid TumorsJunning Cao, Dongmei Ji, Zhiyu Chen, et al.
The Oncologist|May 21, 2017
Health Care Resource Utilization and Associated Costs Among Metastatic Cutaneous Melanoma Patients Treated with Ipilimumab (INTUITION Study)Grant A McArthur, Peter Mohr, Paolo Antonio Ascierto, et al.
The Oncologist|May 27, 2018
Immune Checkpoint Inhibitor-Associated MyocarditisSarju Ganatra, Tomas G Neilan
The Oncologist|May 10, 2018
Long-Term Survival Rates of Patients with Stage III-IV Hodgkin Lymphoma According to Age, Sex, Race, and Socioeconomic Status, 1984-2013Yushi Li, Huanhuan Sun, Yan Yan, et al.
Pageof 571